Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-08-03
DOI
10.1038/srep12728
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Codon optimization of genes for efficient protein expression in mammalian cells by selection of only preferred human codons
- (2015) Satoshi Inouye et al. PROTEIN EXPRESSION AND PURIFICATION
- Molecular Chaperone Functions in Protein Folding and Proteostasis
- (2013) Yujin E. Kim et al. Annual Review of Biochemistry
- C6-Deoxy coelenterazine analogues as an efficient substrate for glow luminescence reaction of nanoKAZ: The mutated catalytic 19kDa component of Oplophorus luciferase
- (2013) Satoshi Inouye et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Prospects for Improving Brain Function in Individuals with Down Syndrome
- (2013) Alberto C. S. Costa et al. CNS DRUGS
- Chaperones as thermodynamic sensors of drug-target interactions reveal kinase inhibitor specificities in living cells
- (2013) Mikko Taipale et al. NATURE BIOTECHNOLOGY
- ATP-competitive inhibitors block protein kinase recruitment to the Hsp90-Cdc37 system
- (2013) Sigrun Polier et al. Nature Chemical Biology
- Structures of Down Syndrome Kinases, DYRKs, Reveal Mechanisms of Kinase Activation and Substrate Recognition
- (2013) Meera Soundararajan et al. STRUCTURE
- Kinome Render: a stand-alone and web-accessible tool to annotate the human protein kinome tree
- (2013) Matthieu Chartier et al. PeerJ
- Recent Advances in the Design, Synthesis, and Biological Evaluation of Selective DYRK1A Inhibitors: A New Avenue for a Disease Modifying Treatment of Alzheimer’s?
- (2012) Breland Smith et al. ACS Chemical Neuroscience
- Quantitative Analysis of Hsp90-Client Interactions Reveals Principles of Substrate Recognition
- (2012) Mikko Taipale et al. CELL
- β-Carboline Compounds, Including Harmine, Inhibit DYRK1A and Tau Phosphorylation at Multiple Alzheimer's Disease-Related Sites
- (2011) Danielle Frost et al. PLoS One
- Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
- (2010) Tatyana Adayev et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The role of DYRK1A in neurodegenerative diseases
- (2010) Jerzy Wegiel et al. FEBS Journal
- Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
- (2010) Yasushi Ogawa et al. Nature Communications
- Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation
- (2009) Nora Göckler et al. FEBS Journal
- Protein Kinase Activation Loop Autophosphorylation in Cis: Overcoming a Catch-22 Situation
- (2009) P. A. Lochhead Science Signaling
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now